Use of corticosteroids in septic shock

Minerva Anestesiologica

Volumn 77, Issue 2, 2011, Pages 190-195

  Cohen, R ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Adrenal cortex hormones; Clinical trials as topic; Shock, septic

Indexed keywords

CORTICOSTEROID; FLUDROCORTISONE; HYDROCORTISONE; PLACEBO;

ADRENAL INSUFFICIENCY; ADULT RESPIRATORY DISTRESS SYNDROME; ANTIINFLAMMATORY ACTIVITY; CLINICAL EFFECTIVENESS; CORTICOSTEROID THERAPY; CRITICAL ILLNESS; DISEASE SEVERITY; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG USE; GASTROINTESTINAL HEMORRHAGE; HUMAN; INFECTION; LOW DRUG DOSE; PNEUMOCYSTIS PNEUMONIA; RESPIRATORY FAILURE; REVIEW; SEPTIC SHOCK; SHORT COURSE THERAPY; TREATMENT DURATION; TREATMENT PLANNING;

ADRENAL CORTEX HORMONES; ANTI-INFLAMMATORY AGENTS; CRITICAL ILLNESS; GUIDELINES AS TOPIC; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SHOCK, SEPTIC;

EID: 79953092757     PISSN: 03759393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. Colin G, Annane D. Corticosteroids and human recombinant activated protein C for septic shock. Clin Chest Med 2008;29:705-12.
2. Galon J, Franchimont D, Hiroi N, Frey G, Boettner A, Ehrhart-Bornstein M et al. Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells. FASEB J 2002;16:61-71.
3. Wachter RM, Luce JM, Turner J, Volberding P, Hopewell PC. Intensive care of patients with the acquired immunodeficiency syndrome: outcome and changing pattern of utilization. Am Rev Respir Dis 1986;134:891-6.
4. Luks AM, Neff MJ. Pneumocystis jiroveci pneumonia. Respir Care 2007;52:59-63.
5. McGee S, Hirschmann J. Use of corticosteroids in treating infectious diseases. Arch Intern Med 2008;168:1034-46.
6. Marshall JC, Chabonney E, Gonzalez PD. The immune system in critical illness. Clin Chest Med 2008;29:605-16.
7. Russell JA. Management of sepsis. N Engl J Med 2006;355:1699-71.
8. Weigelt JA, Norcross JF, Borman KR, Snyder WH. Early steroid therapy for respiratory failure. Arch Surg 1985;120:536-40.
9. Bone RC, Fisher CJ, Clemmer TP, Slotman GJ, Metz CA. Early methylprednisolone treatment for septic syndrome and the adult respiratory distress syndrome. Chest 1987;92:1032-6.
10. Sprung CL, Caralis PV, Marcial EH, Pierce M, Gelbard MA, Long WM et al. The effects of high-dose corticosteroids in patients with septic shock. A prospective, controlled study. N Engl J Med 1984;311:1137-43.
11. The Veterans Administration Systemic Sepsis Cooperative Study Group. Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis. N Engl J Med 1987;317:659-65.
12. Goldberg PA, Inzucchi SE. Critical issues in endocrinology. Clin Chest Med 2003;24:583-606.
13. Annane D, Sebille V, Troche G, Raphael JC, Gajdos P, Bellissant E. A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotrophin. JAMA 2000;283:1038-45.
14. Annane D, Sebille V, Charpentier C, Bollaert PE, Francois B, Korach JM et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002;288:862-71.
15. Hamrahian AH, Oseni TS, Arafah BM. Measurements of Serum Free Cortisol in Critically Ill Patients. N Engl J Med 2004;350:1629-38.
16. Sprung CL, Annane D, Keh D, Moreno R, Singer M, Freivogel K et al. Hydrocortisone therapy for patients with septic shock. N Engl J Med 2008;358:111-24.
17. Saito T, Takanashi M, Gallagher E, Fuse A, Suzaki S, Inagaki O et al. Corticosteroid effect on early beta-adrenergic down-regulation during circulatory shock: hemodynamic study and beta-adrenergic receptor assay. Intensive Care Med 1995;3:204-10.
18. Annane D, Bellissant E, Bollaert PE, Briegel J, Confalonieri M, De Gaudio R et al. Corticosteroids in the treatment of severe sepsis and septic shock in adults: a systematic review. JAMA 2009;301:2362-75.
19. Suffredini AF, Masur H, Lynch JP III. Update in Pulmonary and Critical Care Medicine. Ann Intern Med 2010;152:601-8.
20. Bailar JC. The promise and pitfalls of meta-analysis. N Engl J Med 1997;337:559-61.
21. Delaney A, Bagshaw SM, Ferland A, Manns B, Laupland KB, Doig CJ. A systematic evaluation of the quality of meta-analyses in the critical care literature. Critical Care 2005;9:R575-R82.
22. Reade MC, Delaney A, Bailey MJ, Angus DC. Benchto-bedside review: Avoiding pitfalls in critical care metaanalysis - funnel plots, risk estimates, types of heterogeneity, baseline risk and the ecologic fallacy. Critical Care 2008;2:220.
23. Beale R, Janes JM, Brunkhorst FM, Dobb G, Levy MM, Martin GS et al. Global utilization of low-dose corticosteroids in severe sepsis and septic shock: a report from the PROGRESS registry. Crit Care 2010;14:R102.
24. Annane D. Corticosteroids for sepsis: registry versus Cochrane systematic review! Critical Care 2010;14:185.
25. Marik PE, Pastores SM, Annane D, Meduri GU, Sprung CL, Arlt W et al. Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med 2008;36:1937-49.
26. Dellinger RP. Steroid therapy of septic shock: the decision is in the eye of the beholder. Crit Care Med 2008;36:1987-9.
27. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R et al. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock. Crit Care Med 2008;36:296-327.
28. De Jonghe B, Sharshar T, Lefaucheur JP, Authier F-J, Durand-Zaleski I, Boussarsar M et al.; for the Groupe de Réflexion et d'Etude des Neuromyopathies en Réanimation. Paresis Acquired in the Intensive Care Unit. A Prospective Multicenter Study. JAMA 2002;288:2859-67.